...
首页> 外文期刊>European Journal of Radiology >Efficacy of pre-scan beta-blockade and impact of heart rate on image quality in patients undergoing coronary multidetector computed tomography angiography.
【24h】

Efficacy of pre-scan beta-blockade and impact of heart rate on image quality in patients undergoing coronary multidetector computed tomography angiography.

机译:进行冠状动脉多探测器计算机断层扫描血管造影的患者,预扫描β受体阻滞剂的功效和心率对图像质量的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: While beta-blockers are routinely administered to patients prior to coronary computed tomography angiography (CTA), their effectiveness is unknown. We therefore assessed the efficacy of beta-blockade with regards to heart rate (HR) control and image quality in an unselected patient cohort. METHODS: We studied 150 consecutive patients (104 men/46 female; mean age, 56+/-13 years) referred for coronary CTA. Intravenous metoprolol (5-20mg) was administered to patients with a HR >65 beats per minute (bpm). The goal HR was defined as an average HR <65 bpm without a single measurement above 68 bpm. RESULTS: Overall, 45% (68/150) of patients met the HR criteria for beta-blocker administration of which 76% (52/68) received metoprolol (mean dose 12+/-10mg). Of the 52 patients who received beta-blocker versus the 98 who did not, 18 (35%) versus 62 (64%) patients achieved the goal HR, respectively. All patients who achieved the target HR had an evaluable CTA while five patients who did not achieve the target HR had at least one non-evaluable coronary artery due to motion artifact. There was also a significant reduction in any motion artifact among those who achieved the goal HR as compared to those who did not (p=0.001). Logistic regression revealed an increase in the odds of stair step artifact of 11.6% (95% CI: 2.4% decrease, 27.5% increase) per 1 bpm increase in the standard deviation of scan HR. CONCLUSION: Overall, efficacy of beta-blocker administration to reach target HR is limited. Improvements in CT scanner temporal resolution are mandatory to achieve consistently high image quality independent of HR and beta-blocker administration.
机译:目的:尽管在冠状动脉计算机断层扫描血管造影(CTA)之前对患者常规使用β受体阻滞剂,但其有效性尚不清楚。因此,我们在未选择的患者队列中评估了β受体阻滞剂在心率(HR)控制和图像质量方面的功效。方法:我们研究了150例连续的患者(冠心病CTA),其中男104例,女46例;平均年龄56 +/- 13岁。 HR> 65次/分钟(bpm)的患者静脉注射美托洛尔(5-20​​mg)。目标HR定义为平均HR <65 bpm,而没有单次测量高于68 bpm的情况。结果:总体而言,有45%(68/150)的患者达到了β受体阻滞剂的HR标准,其中76%(52/68)的患者接受了美托洛尔(平均剂量12 +/- 10mg)。在接受β受体阻滞剂的52例患者中,没有接受β受体阻滞剂的98例中,分别有18例(35%)对62例(64%)达到了目标HR。所有达到目标HR的患者均具有可评估的CTA,而五位未达到目标HR的患者因运动伪影而具有至少一个不可评估的冠状动脉。与未达到目标HR的人相比,达到目标HR的人的运动伪影也显着减少(p = 0.001)。 Logistic回归显示,扫描HR的标准偏差每增加1 bpm,阶梯伪影的几率就会增加11.6%(95%CI:减少2.4%,增加27.5%)。结论:总体而言,β受体阻滞剂给药达到目标HR的功效有限。必须不断改进CT扫描仪的时间分辨率,以实现始终如一的高图像质量,而不受HR和β受体阻滞剂的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号